XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2025
Dec. 31, 2024
Current Assets    
Cash $ 36,228,305 $ 35,004,924
Accounts receivable, net 7,330,129 8,217,813
Product deposit 251,000 40,763
Inventory, net 3,251,355 2,797,358
Other current assets 1,964,974 2,672,231
Total Current Assets 49,025,763 48,733,089
Non-current Assets    
Equipment, net 2,050,318 1,479,184
Right of use assets 5,822,907 6,400,596
Capitalized software, net 14,837,946 13,816,501
Intangible assets, net 1,827,768 2,030,656
Total Non-current Assets 24,538,939 23,726,937
Total Assets 73,564,702 72,460,026
Current Liabilities    
Accounts payable 24,292,870 16,009,484
Accrued expenses 14,946,499 20,811,763
Current operating lease liabilities 541,981 508,537
Current portion of long-term debt 11,960,784 8,444,444
Deferred revenue 11,790,024 14,480,917
Total Current Liabilities 63,532,158 60,255,145
Long-term Liabilities    
Long-term debt, net 3,517,317 9,885,057
Noncurrent operating lease liabilities 6,032,847 6,265,192
Contingent consideration 100,000 100,000
Total Liabilities 73,182,322 76,505,394
Commitments and contingencies (Note 10)
Mezzanine Equity    
Preferred Stock, $0.0001 par value; 5,000,000 shares authorized Series B Convertible Preferred Stock, $0.0001 par value; 5,000 shares authorized, zero shares issued and outstanding, liquidation value, $0 per share as of June 30, 2025 and December 31, 2024
Stockholders’ Equity (Deficit)    
Series A Preferred Stock, $0.0001 par value; 1,610,000 shares authorized, 1,400,000 shares issued and outstanding, liquidation value approximately, $25.55 per share as of June 30, 2025 and December 31, 2024 140 140
Common Stock, $0.01 par value; 100,000,000 shares authorized, 45,141,226 and 42,293,907 shares issued, 45,038,186 and 42,190,867 outstanding as of June 30, 2025 and December 31, 2024, respectively 451,412 422,939
Additional paid-in capital 236,426,008 230,508,339
Accumulated deficit (238,496,413) (236,253,218)
Treasury stock, 103,040, at cost, as of June 30, 2025 and December 31, 2024 (163,701) (163,701)
Total LifeMD, Inc. Stockholders’ Deficit (1,782,554) (5,485,501)
Non-controlling interest 2,164,934 1,440,133
Total Stockholders’ Equity (Deficit) 382,380 (4,045,368)
Total Liabilities, Mezzanine Equity and Stockholders’ Equity (Deficit) $ 73,564,702 $ 72,460,026